1. National Cancer Institute. SEER data, 1973-2005 [Internet]. Rockville: National Cancer Institute;2008. [cited 2017 Sep 1]. Available from:
http://seer.cancer.gov/.
2. Henson DE, Albores-Saavedra J, Corle D. Carcinoma of the gallbladder: histologic types, stage of disease, grade, and survival rates. Cancer. 1992; 70:1493–7.
Article
3. Liu W, Wang L, He XD, Feng C, Chang XY, Lu ZH. Mixed large cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder: a case report and brief review of the literature. World J Surg Oncol. 2015; 13:114.
Article
4. Buscemi S, Orlando E, Damiano G, et al. "Pure" large cell neuroendocrine carcinoma of the gallbladder: report of a case and review of the literature. Int J Surg. 2016; 28 Suppl 1:S128–32.
Article
5. Eltawil KM, Gustafsson BI, Kidd M, Modlin IM. Neuroendocrine tumors of the gallbladder: an evaluation and reassessment of management strategy. J Clin Gastroenterol. 2010; 44:687–95.
6. Alpuerto AC, Mora ME, Robitsek RJ, Schubl SD. Primary pure squamous cell carcinoma of the gallbladder locally invading the liver, duodenum, and stomach: a case report and literature review. Case Rep Surg. 2017; 2017:2534029.
Article
7. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC Press;2010. p. 274–6.
8. Noske A, Pahl S. Combined adenosquamous and large-cell neuroendocrine carcinoma of the gallbladder. Virchows Arch. 2006; 449:135–6.
Article
9. Kanthan R, Senger JL, Ahmed S, Kanthan SC. Gallbladder cancer in the 21st century. J Oncol. 2015; 2015:967472.
Article
10. Albores-Saavedra J, Nadji M, Henson DE, Angeles-Angeles A. Enteroendocrine cell differentiation in carcinomas of the gallbladder and mucinous cystadenocarcinomas of the pancreas. Pathol Res Pract. 1988; 183:169–75.
Article
11. Christie AC. Three cases illustrating the presence of argentaffin (kultschitzky) cells in the human gall-bladder. J Clin Pathol. 1954; 7:318–21.
Article
12. Hart IR, Fidler IJ. The implications of tumor heterogeneity for studies on the biology of cancer metastasis. Biochim Biophys Acta. 1981; 651:37–50.
13. Hoshimoto S, Hoshi S, Hishinuma S, et al. Adenosquamous carcinoma in the biliary tract: association of the proliferative ability of the squamous component with its proportion and tumor progression. Scand J Gastroenterol. 2017; 52:425–30.
Article
14. Chen C, Wang L, Liu X, Zhang G, Zhao Y, Geng Z. Gallbladder neuroendocrine carcinoma: report of 10 cases and comparision of clinicopathologic features with gallbladder adenocarcinoma. Int J Clin Exp Pathol. 2015; 8:8218–26.
15. Acosta AM, Wiley EL. Primary biliary mixed adenoneuroendocrine carcinoma (MANEC): a short review. Arch Pathol Lab Med. 2016; 140:1157–62.
Article
16. Verlicchi L, Blons H, Hannoun L, Bachet JB. Squamous-cell gallbladder carcinoma: how to treat? J Cell Sci Ther. 2015; 6:212.
Article